rs37370

This is a protein-altering variant in the AGXT2 gene.

GWAS Catalog Trait Associations (7)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

3-aminoisobutyrate measurement

Allele T
OR 1.06
p
N 14,296
Large GWAS
European
Allele T
OR 0.95
p
N 8,809
Large GWAS
European

serum metabolite level

Allele C
OR 0.91
p 7.0e-220
N 3,926
Large GWAS
Hispanic or Latin American

beta-aminoisobutyric acid measurement

Allele T
OR 0.89
p 4.0e-210
N 3,863
Large GWAS
multi-ancestry

2-aminoisobutyric acid measurement

Feofanova EV et al. Whole-Genome Sequencing Analysis of Human Metabolome in Multi-Ethnic Populations. Nature Communications 14(1):3111 (2023)
Allele T
OR 0.84
p 6.0e-66
N 2,459
Large GWAS
multi-ancestry

dimethylarginine (SDMA + ADMA) measurement

Allele T
OR 0.22
p 6.0e-38
N 14,296
Large GWAS
European
Allele T
OR 0.24
p 5.0e-23
N 8,233
Large GWAS
European

protein measurement

Allele C
OR
β 0.076
p 9.0e-16
N 287
Small GWAS
multi-ancestry

X-12112 measurement

Allele T
OR 0.17
p 1.0e-10
N 8,211
Large GWAS
European

About AGXT2

The protein encoded by this gene is a class III pyridoxal-phosphate-dependent mitochondrial aminotransferase. It catalyzes the conversion of glyoxylate to glycine using L-alanine as the amino donor. It is an important regulator of methylarginines and is involved in the control of blood pressure in kidney. Polymorphisms in this gene affect methylarginine and beta-aminoisobutyrate metabolism, and are associated with carotid atherosclerosis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]

View all AGXT2 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…